GlassScriptPhysician profile
Shaunda Kelly
NPI 1659540508
$1,505.51
in general payments reported to CMS, 2019-2025
13 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2021: $63.21 · 2022: $535 · 2023: $30.52 · 2024: $251 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441 · Gift: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.74 |
| Gift | $251.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $515.07 | 2022-2025 | |
| Kerr Corporation | $372.94 | 2022 | |
| Biohorizons Implant Systems INC. | $157.62 | 2019-2025 | Biohorizons Dental Implants |
| Somnomed INC. | $119.65 | 2025 | |
| Stryker Corporation | $102.68 | 2019 | |
| Zimvie INC. | $90.35 | 2025 | |
| Zimmer Biomet Holdings, INC. | $38.78 | 2021 | |
| Dentsply Sirona INC | $24.43 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.78 | 2022 | |
| Envista Holdings Corporation | $17.24 | 2025 | Maxcem Elite |
| Orapharma, A Division of Bausch Health US, LLC | $16.45 | 2022 | |
| Geistlich Pharma, North America, INC. | $15.40 | 2023 | Bio-Materials |
| Kowa Pharmaceuticals America, INC. | $15.12 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaunda Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.